SUMMARY Multiple sclerosis is a complex disease which presents a unique challenge in clinical management. This decade has seen the advent of new therapies which are partially effective in modifying the disease course. However, current therapies have no impact on existing neurological deficits and so supportive measures, symptomatic treatment and comprehensive rehabilitation remain at the core of management. Historically clinical practice has often been empirical but management should now be evidence‐based and guided by consensus opinion if improvements in care are to be made. (Int J Clin Pract 2000; 54(3): 161‐169)
No takes yet. Share an insight, caveat, or question.
Leary et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: